FDA Drug Application (020358) for WELLBUTRIN SR by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020358
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameWELLBUTRIN SR
Active IngredientBUPROPION HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7


Back to FDA Applications sponsored by GLAXOSMITHKLINE